Paid Clinical Trials for Graft Versus Host Disease

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing all 5 results

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

by CTG

in Chronic Myelomonocytic Leukemia in Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Graft Versus Host Disease

Other

New York

Deadline:

05/21/2027

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

by CTG

in Graft Versus Host Disease, Myelodysplastic Syndrome, Acute Myeloid Leukemia

Other

California

Deadline:

05/25/2027

Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

by CTG

in Graft Versus Host Disease

Other

Maryland

Deadline:

03/03/2026

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

by CTG

in Chronic Lung Disease, Hematopoietic Cell Transplantation, Graft Versus Host Disease

Other

California

Deadline:

05/01/2028

Optimizing PTCy Dose and Timing

by CTG

in Hematologic Neoplasms, Graft Versus Host Disease

Other

Maryland

Deadline:

05/29/2026